Phase II Study of Cetuximab Combined With IMRT and Concurrent Chemotherapy of Cisplatin in Nasopharyngeal Carcinoma.

Trial Profile

Phase II Study of Cetuximab Combined With IMRT and Concurrent Chemotherapy of Cisplatin in Nasopharyngeal Carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Cetuximab (Primary) ; Cisplatin
  • Indications Nasopharyngeal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ENCORE
  • Most Recent Events

    • 02 Jun 2015 Five-year follow-up results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 31 Mar 2010 Additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 31 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top